Education
Catalog Advanced Search
176 Results
-
SMFM Webinar Series: Ethnicity-Based Genetic Carrier Screening
Contains 2 Component(s)Speaker: Jeff Kuller At the completion of this lecture the viewer should understand : 1-Which ethnic groups are at the highest risk for genetic disorders; 2-The genetic disorders to screen for (their pathophysiology, mode of testing, carrier frequency and prenatal diagnosis); 3-The most common hemoglobinopathies and how to screen for them and 4-ACOG's recommendations
-
SMFM Webinar Series: Perinatal Risk Factors for Autism - Talking Points for the Obstetrician
Contains 2 Component(s)Speaker: Erin Clark The main objectives of this presentation are to: 1-Define autism; 2-Review the epidemiologic data; 3-Discuss perinatal risk factors and 4-Become better equipped to counsel patients for autism risk factors
-
SMFM Webinar Series: OB Pharmacology - Part 2
Contains 2 Component(s)Speaker: Steve Caritis The main objectives of this presentation are to: 1-Discuss the determinants of placental transport; 2-Present teratogens, toxicants and other fetal effects; 3-Present the FDA rule on pregnancy and; 4-Present the mechanism and regulators of drug transfer in breast milk
-
SMFM Webinar Series: OB Pharmacology
Contains 2 Component(s)Speaker: Steve Caritis The main objectives of this presentation are to: 1-Present the scope of the problem of medication use in pregnancy; 2-Present the FDA risk classification in pregnancy; 3-Review pregnancy effects on drug absorption, distribution, metabolism and elimination and; 4-Discuss pharmacodynamics in pregnancy
-
SMFM Webinar Series: Update On VTE In Pregnancy: CHEST Guidelines
Contains 2 Component(s)Speaker: Andra James The main objectives of this presentation are to: 1-Present the guidelines for VTE prophylaxis in pregnancy; 2-Present the purpose and methodology of ACCP guidelines; 3-Discuss the recommendations for anticoagulant use in pregnancy and lactation and 4-Discuss the management of acute VTE and VTE thromboprophylaxis in high risk patients
-
SMFM Webinar Series: Non-Invasive Prenatal Testing (NIPT)
Contains 2 Component(s)Speaker: Mary Norton The main objectives of this presentation are to: 1-Explain the biology behind testing of cfDNA in maternal serum; 2-Describe the technologies employed to evaluate cfDNA and risk for fetal aneuploidy; 3-Discuss some of the biologic complexities of this technology and 4-Explain the differences between different aneuploidies and test outcome
-
SMFM Webinar Series: Inflammatory Bowel Disease
Contains 2 Component(s)Speaker: Chad Grotegut Dr Chad Grotegut discusses inflammatory bowel disease in pregnancy. He reviews the use of medications including biologics and aspirin in pregnancy as well as the issue of mode of delivery.
-
SMFM Webinar Series: Open Fetal Surgery for Life-Threatening Lesions
Contains 2 Component(s)Speaker: Darrell Cass The main objectives of this presentation are to discuss: 1-General fetal surgery concepts; 2-The role of prenatal diagnosis; 3-Fetal surgery for specific life-threatening conditions and 4-EXIT procedure
-
SMFM Webinar Series: Maternal Congenital Heart Disease and Pregnancy Outcomes
Contains 2 Component(s)Speaker: Torri Metz The main objectives of this presentation are to: 1-Describe the normal physiologic changes in the cardiac system in pregnancy; 2-Describe pregnancy outcomes in women with congenital heart disease; 3-Discuss appropriate antepartum and intrapartum management plans for women with congenital heart disease and 4-Understand how to stratify risk for women with congenital heart disease based on lesion and cardiac history
-
SMFM Webinar Series: Modern Management of Red Cell Immunization
Contains 2 Component(s)Speaker: Ken Moise At the completion of this lecture the physician should: 1- Be aware of the role of cfDNA in determining the fetal RHD status in an alloimmunized pregnancy; 2-Be able to explain the evolving role of cfDNA in determining which patient should receive antenatal Rhesus immune globulin; 3-Understand proper reporting and use of MCA Doppler and 4-Understand the management of the alloimmunized pregnancy
